Article ID Journal Published Year Pages File Type
6074222 Journal of Dermatological Science 2015 10 Pages PDF
Abstract
DHE-Glc improved AD-like skin inflammatory symptoms on the backs of DNCB-induced mice, partly by suppressing production of Th2 chemokines, CCL17 and CCL22 in inflamed skin. Therefore, DHE-Glc is a potential therapeutic agent for skin inflammatory diseases such as AD.
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Authors
, , , , , , ,